Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Ovarian Neoplasms × budigalimab × 1 year × Clear all

Sponsor

Conditions

Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Squamous Cell Carcinoma of Head and Neck 5 Triple Negative Breast Neoplasms 3 Carcinoma, Hepatocellular 3 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Colorectal Neoplasms 2 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Melanoma 1 Esophageal Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Neuroendocrine 1 Anophthalmia with pulmonary hypoplasia 1

Interventions

Paclitaxel 56 Bevacizumab 56 Carboplatin 52 pembrolizumab 40 olaparib 31 Specimen Handling 26 niraparib 23 Gemcitabine 23 Magnetic Resonance Spectroscopy 21 Cyclophosphamide 21 Nivolumab 19 Cisplatin 18 Biopsy 18 Taxes 17 liposomal doxorubicin 16 fludarabine 14 Fulvestrant 13 Topotecan 12 Immunoglobulin G 11 Doxorubicin 11 Disulfides 11 durvalumab 10 Oxaliplatin 10 Ipilimumab 9 mirvetuximab soravtansine 8 aldesleukin 8 Fluorouracil 8 Docetaxel 8 Blood Specimen Collection 8 atezolizumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡